IONS Insider Transactions — Page 11
1,448 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1,001–1,100; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| CROOKE STANLEY T | Chairman and CEO | 2013-06-26 | Sale | 10,000.0 | $26.7 |
| CROOKE STANLEY T | Chairman and CEO | 2013-06-26 | Sale | 20,000.0 | $27.1 |
| CROOKE STANLEY T | Chairman and CEO | 2013-06-25 | Sale | 19,565.0 | $27.87 |
| CROOKE STANLEY T | Chairman and CEO | 2013-06-25 | Sale | 10,435.0 | $28.32 |
| Geary Richard S | SVP, Development | 2013-06-25 | Sale | 10,435.0 | $27.87 |
| Geary Richard S | SVP, Development | 2013-06-25 | Sale | 1,565.0 | $28.32 |
| Geary Richard S | SVP, Development | 2013-06-25 | Sale | 4,000.0 | $28.32 |
| Geary Richard S | SVP, Development | 2013-06-25 | Sale | 1,049.0 | $27.56 |
| CROOKE STANLEY T | Chairman and CEO | 2013-06-24 | Sale | 13,730.0 | $25.22 |
| CROOKE STANLEY T | Chairman and CEO | 2013-06-24 | Sale | 16,270.0 | $25.16 |
| Geary Richard S | SVP, Development | 2013-06-24 | Sale | 10,000.0 | $25.16 |
| Geary Richard S | SVP, Development | 2013-06-24 | Sale | 6,270.0 | $25.16 |
| Geary Richard S | SVP, Development | 2013-06-24 | Sale | 13,730.0 | $25.22 |
| WENDER JOSEPH H | Director | 2013-06-20 | Sale | 5,447.0 | $20.93 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2013-06-11 | Sale | 9,375.0 | $23.76 |
| MUTO FREDERICK T | Director | 2013-05-30 | Sale | 10,000.0 | $21.96 |
| BENNETT C FRANK | SVP, Antisense Research | 2013-05-01 | Sale | 6,145.0 | $22.26 |
| BENNETT C FRANK | SVP, Antisense Research | 2013-05-01 | Sale | 23,800.0 | $22.26 |
| BENNETT C FRANK | SVP, Antisense Research | 2013-04-30 | Sale | 30,000.0 | $22.51 |
| PARSHALL B LYNNE | COO, Secretary | 2013-04-25 | Sale | 18,400.0 | $22.5 |
| PARSHALL B LYNNE | COO, Secretary | 2013-04-25 | Sale | 7,454.0 | $22.5 |
| PARSHALL B LYNNE | COO, Secretary | 2013-04-24 | Sale | 30,000.0 | $22.12 |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2013-04-24 | Sale | 10,417.0 | $22.38 |
| CROOKE STANLEY T | Chairman, CEO and President | 2013-04-24 | Sale | 10,000.0 | $22.12 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-23 | Sale | 3,900.0 | $22.13 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-23 | Sale | 1,800.0 | $22.13 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-23 | Sale | 2,700.0 | $22.13 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-23 | Sale | 2,260.0 | $22.13 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-23 | Sale | 10,660.0 | $22.13 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-23 | Sale | 6,000.0 | $22.13 |
| PARSHALL B LYNNE | COO, Secretary | 2013-04-23 | Sale | 10,000.0 | $22.1 |
| PARSHALL B LYNNE | COO, Secretary | 2013-04-23 | Sale | 10,000.0 | $22.1 |
| PARSHALL B LYNNE | COO, Secretary | 2013-04-23 | Sale | 10,000.0 | $22.1 |
| CROOKE STANLEY T | Chairman, CEO and President | 2013-04-23 | Sale | 30,000.0 | $22.1 |
| PARSHALL B LYNNE | COO, Secretary | 2013-04-22 | Sale | 30,000.0 | $20.99 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2013-04-22 | Sale | 17,000.0 | $21.26 |
| CROOKE STANLEY T | Chairman, CEO and President | 2013-04-22 | Sale | 10,000.0 | $20.99 |
| CROOKE STANLEY T | Chairman, CEO and President | 2013-04-22 | Sale | 20,000.0 | $20.99 |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2013-04-22 | Sale | 2,000.0 | $21.43 |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2013-04-22 | Sale | 3,000.0 | $21.41 |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2013-04-22 | Sale | 2,813.0 | $21.4 |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2013-04-22 | Sale | 9,843.0 | $21.49 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-19 | Sale | 5,000.0 | $21.01 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-19 | Sale | 6,000.0 | $20.01 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-19 | Sale | 1,000.0 | $19.6 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-04-19 | Sale | 3,000.0 | $20.25 |
| PARSHALL B LYNNE | COO, Secretary | 2013-04-19 | Sale | 30,000.0 | $20.01 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2013-04-19 | Sale | 2,500.0 | $21.25 |
| CROOKE STANLEY T | Chairman, CEO and President | 2013-04-19 | Sale | 30,000.0 | $20.01 |
| Geary Richard S | SVP, Development | 2013-04-19 | Sale | 2,042.0 | $20.8 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-04-12 | Sale | 4,330.0 | $19.62 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-04-12 | Sale | 1,130.0 | $19.6 |
| Geary Richard S | Sr VP, Development | 2013-04-11 | Sale | 7,000.0 | $19.52 |
| Geary Richard S | Sr VP, Development | 2013-03-21 | Sale | 1,000.0 | $19.5 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-03-21 | Sale | 9,000.0 | $19.26 |
| HOUGEN ELIZABETH L | SVP, Finance and CFO | 2013-03-20 | Sale | 4,792.0 | $18.13 |
| HOUGEN ELIZABETH L | SVP, Finance and CFO | 2013-03-20 | Sale | 9,584.0 | $18.13 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 174.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 1,250.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 2,500.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 4,167.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 3,750.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 174.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 1,250.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 2,500.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 4,167.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 3,750.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 173.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 1,250.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 2,500.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 4,166.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-20 | Sale | 3,750.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-19 | Sale | 3,727.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-19 | Sale | 3,726.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-19 | Sale | 3,726.0 | $18.0 |
| KLEIN JOSEPH III | Director | 2013-03-13 | Sale | 6,667.0 | $18.01 |
| KLEIN JOSEPH III | Director | 2013-03-13 | Sale | 266.0 | $18.01 |
| KLEIN JOSEPH III | Director | 2013-03-13 | Sale | 6,667.0 | $18.01 |
| KLEIN JOSEPH III | Director | 2013-03-13 | Sale | 266.0 | $18.01 |
| KLEIN JOSEPH III | Director | 2013-03-13 | Sale | 6,666.0 | $18.01 |
| KLEIN JOSEPH III | Director | 2013-03-13 | Sale | 268.0 | $18.01 |
| HOUGEN ELIZABETH L | SVP, Finance and CFO | 2013-03-05 | Sale | 5,040.0 | $16.86 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2013-03-05 | Sale | 18,240.0 | $16.86 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-03-04 | Sale | 1,350.0 | $15.82 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-03-04 | Sale | 10,350.0 | $15.82 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-02-19 | Sale | 1,600.0 | $14.8 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-02-15 | Sale | 250.0 | $14.82 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-02-15 | Sale | 100.0 | $14.8 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-02-13 | Sale | 139.0 | $14.17 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-02-13 | Sale | 5,200.0 | $14.17 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-02-13 | Sale | 900.0 | $14.17 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-01-30 | Sale | 2,000.0 | $14.82 |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2013-01-29 | Sale | 300.0 | $13.4 |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2013-01-17 | Sale | 242.0 | $14.16 |
| BENNETT C FRANK | SVP, Antisense Research | 2013-01-16 | Sale | 309.0 | $14.0 |
| Geary Richard S | SVP, Development | 2013-01-16 | Sale | 345.0 | $14.0 |
| CROOKE STANLEY T | Chairman, CEO and President | 2013-01-16 | Sale | 143.0 | $14.0 |
| CROOKE STANLEY T | Chairman, CEO and President | 2013-01-16 | Sale | 1,317.0 | $14.0 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2013-01-16 | Sale | 95.0 | $14.0 |
| Monia Brett P | SVP, Antisense Drug Discovery | 2013-01-16 | Sale | 235.0 | $14.0 |